| Schedule of Computation of Basic and Diluted Earnings per Share |
The following table sets forth the computation of basic and diluted earnings per share attributable to common stockholders for the periods presented (in thousands, except per share and share amounts): | | | | | | | | | | | | | | | | | Three Months Ended April 30, | | | | 2026 | | 2025 | | | | | | | | | | | | | | Basic earnings per share | | | | | | | | | Numerator: | | | | | | | | | Net income attributable to common stockholders | $ | 12,834 | | | $ | 25,947 | | | | | | | Denominator: | | | | | | | | | Weighted-average number of common stock outstanding used in computing earnings per share, basic | 151,724,284 | | 40,271,969 | | | | | | Earnings per share attributable to common stockholders, basic | $ | 0.08 | | | $ | 0.64 | | | | | | | | | | | | | | | Diluted earnings per share | | | | | | | | | Numerator: | | | | | | | | | Net income attributable to common stockholders, basic | $ | 12,834 | | | $ | 25,947 | | | | | | | | | | | | | | | | | | | | | | | Fair value adjustment for liability-classified common stock warrant, net of tax effect | (11) | | — | | | | | | | Net income attributable to common stockholders, dilutive | $ | 12,823 | | | $ | 25,947 | | | | | | | Denominator: | | | | | | | | | Weighted-average number of common stock outstanding used in computing earnings per share, basic | 151,724,284 | | 40,271,969 | | | | | | | | | | | | | | Conversion of redeemable convertible preferred stock, all series | — | | 69,852,421 | | | | | | Dilutive effect of unvested RSUs | 4,293,612 | | — | | | | | | Dilutive effect of stock options | 18,673,450 | | 30,780,811 | | | | | | Dilutive effect of equity-classified common stock warrants | 785,884 | | 1,337,133 | | | | | | Dilutive effect of liability-classified Series G Warrant | — | | 190,465 | | | | | | | Dilutive effect of liability-classified common stock warrant | 23,624 | | 55,036 | | | | | | | Weighted-average number of common stock outstanding used in computing earnings per share, dilutive | 175,500,854 | | | 142,487,835 | | | | | | | Earnings per share attributable to common stockholders, diluted | $ | 0.07 | | | $ | 0.18 | | | | | |
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
The following common stock equivalents were excluded from the computation of diluted earnings per share attributable to common stockholders because including them would have been antidilutive (outstanding): | | | | | | | | | | | | | | | | | Three Months Ended April 30, | | | | 2026 | | 2025 | | | | | | | | | | | | | | Series G Warrant | 251,750 | | | — | | | | | | | RSUs | — | | | 33,493,691 | | | | | | | SAFEs | — | | | Various | | | | |
|